MedTrace Logo

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

NCT05790356 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-08-21

No results posted yet for this study

Summary

This clinical trial will investigate the effects of capsules containing stool from healthy donors, called fecal microbial transplant (FMT), in rheumatoid arthritis patients.

Conditions

  • Arthritis
  • Arthritis, Rheumatoid
  • Fecal Microbiota Transplantation

Interventions

DRUG

Fecal Microbial transplant

Fecal microbial transplant will be investigated for its effect on gut bacterial composition in patients with rheumatoid arthritis.

OTHER

Placebo capsules

The placebo capsules will not contain FMT but will have the same appearance.

Sponsors & Collaborators

  • St. Joseph's Health Care London

    collaborator OTHER

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Lillian Barra, MD, MPH · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2025-08-01
Completion
2026-04-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05790356 on ClinicalTrials.gov